XML 20 R9.htm IDEA: XBRL DOCUMENT v3.4.0.3
Cash, Cash Equivalents and Marketable Securities
3 Months Ended
Mar. 31, 2016
Cash Cash Equivalents And Short Term Investments [Abstract]  
Cash, Cash Equivalents and Marketable Securities

3. Cash, cash equivalents and marketable securities

The following is a summary of cash, cash equivalents and marketable securities available-for-sale as of March 31, 2016 and December 31, 2015 (in thousands): 

 

Amortized Cost

 

 

Unrealized Gains

 

 

Unrealized Losses

 

 

Estimated Fair Value

 

March 31, 2016

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash

$

6,030

 

 

$

-

 

 

$

-

 

 

$

6,030

 

Money market funds

 

24,982

 

 

 

-

 

 

 

-

 

 

 

24,982

 

U.S. Government agency securities

 

4,999

 

 

 

-

 

 

 

-

 

 

 

4,999

 

Corporate debt securities

 

2,847

 

 

 

-

 

 

 

-

 

 

 

2,847

 

Total cash and cash equivalents

 

38,858

 

 

 

-

 

 

 

-

 

 

 

38,858

 

Marketable securities available-for-sale:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. Treasuries

 

6,573

 

 

 

2

 

 

 

(1

)

 

 

6,574

 

U.S. Government agency securities

 

24,604

 

 

 

8

 

 

-

 

 

 

24,612

 

Corporate debt securities

 

96,691

 

 

 

112

 

 

-

 

 

 

96,803

 

Total marketable securities available-for-sale

 

127,868

 

 

 

122

 

 

 

(1

)

 

 

127,989

 

Total cash, cash equivalents and marketable securities

$

166,726

 

 

$

122

 

 

$

(1

)

 

$

166,847

 

December 31, 2015

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash and cash equivalents:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Cash

$

4,561

 

 

$

-

 

 

$

-

 

 

$

4,561

 

Money market funds

 

21,193

 

 

 

-

 

 

 

-

 

 

 

21,193

 

Corporate debt securities

 

19,052

 

 

 

7

 

 

 

(1

)

 

 

19,058

 

Total cash and cash equivalents

 

44,806

 

 

 

7

 

 

 

(1

)

 

 

44,812

 

Marketable securities available-for-sale:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. Government agency securities

 

17,628

 

 

 

-

 

 

 

(6

)

 

 

17,622

 

Corporate debt securities

 

133,679

 

 

 

71

 

 

 

(59

)

 

 

133,691

 

Total marketable securities available-for-sale

 

151,307

 

 

 

71

 

 

 

(65

)

 

 

151,313

 

Total cash, cash equivalents and marketable securities

$

196,113

 

 

$

78

 

 

$

(66

)

 

$

196,125

 

 

The maturities of our marketable securities available-for-sale are as follows (in thousands):

 

 

 

March 31, 2016

 

 

 

Amortized Cost

 

 

Estimated Fair Value

 

Mature in one year or less

 

$

127,868

 

 

$

127,989

 

Mature after one year through two years

 

 

-

 

 

 

-

 

 

 

$

127,868

 

 

$

127,989

 

 

We have classified our entire investment portfolio as available-for-sale and available for use in current operations and accordingly have classified all investments as short-term. Available-for-sale securities are carried at fair value, with unrealized gains and losses included in accumulated other comprehensive income (loss) in stockholders’ equity. Realized gains and losses and declines in value, if any, judged to be other than temporary on available-for-sale securities are included in interest income or expense. The cost of securities sold is based on the specific identification method. Management assesses whether declines in the fair value of investment securities are other than temporary. In determining whether a decline is other than temporary, management considers the following factors:

 

·

Whether the investment has been in a continuous realized loss position for over 12 months;

 

·

the duration to maturity of our investments;

 

·

our intention and ability to hold the investments to maturity and if it is not more likely than not that we will be required to sell the investment before recovery of the amortized cost bases;

 

·

the credit rating, financial condition and near-term prospects of the issuer; and

 

·

the type of investments made.

To date, there have been no declines in fair value that have been identified as other than temporary.